EP4054537
ORAL FORMULATION OF X842
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
4.11.2020EP published:
7.6.2023EP application number:
20801237.7
EPO information:
European Patent Register
Max expiry date:
3.11.2040
Title in English:
ORAL FORMULATION OF X842Language of the patent:
English
Timeline
Today
4.11.2020EP application
7.6.2023EP Publication
Owner
Name:
Cinclus Pharma Holding AB (publ)Address:
Kungsbron 1, Level 3, Elevator G, 111 22 Stockholm, SE
Inventor
Name:
ANDERSSON, KjellAddress:
437 31 Lindome, SE
Name:
SPRINGFELTER, MattiasAddress:
192 74 Sollentuna, SE
Name:
YOUSEF, GabriellaAddress:
172 39 Sundbyberg, SE
Priority
Number:
1951255Date:
4.11.2019Country:
SE
Classification
Categories:
A61K 9/20, A61K 31/437, A61P 1/04